Brucine Inhibits Gastric Cancer via Activation of Ferroptosis Through Regulating the NF-κB Signaling Pathway
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Brucine, a natural alkaloid, effectively combats gastric cancer (GC) by inhibiting cell growth and inducing apoptosis and ferroptosis. This compound shows promise as a novel therapeutic agent for gastric cancer treatment.
Area Of Science
- Oncology
- Pharmacology
- Cell Biology
Background
- Gastric cancer (GC) is a leading cause of cancer mortality globally.
- Late diagnoses highlight the need for novel therapeutic strategies.
- Ferroptosis, a regulated cell death, is implicated in cancer.
Purpose Of The Study
- To investigate the antitumor effects of brucine on gastric cancer cells.
- To explore brucine's mechanisms, including apoptosis and ferroptosis induction.
- To assess brucine's efficacy in vitro and in vivo.
Main Methods
- Brucine treatment of GC cells and xenograft models.
- Assays for cell viability, proliferation, migration, invasion, apoptosis, and ferroptosis.
- Analysis of key molecular markers (Bax, Bcl-2, EMT markers, NF-κB pathway).
Main Results
- Brucine dose-dependently inhibited GC cell proliferation, migration, and invasion.
- Brucine induced apoptosis and potentiated Erastin-induced ferroptosis.
- Brucine reduced tumor growth in vivo and suppressed NF-κB signaling.
Conclusions
- Brucine exhibits significant antitumor activity against gastric cancer.
- Brucine acts via inhibition of proliferation, migration, invasion, and induction of apoptosis and ferroptosis.
- Brucine's effects may be mediated by indirect modulation of the NF-κB pathway.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...